Trial
NCT06001125
Methotrexate for Immune Related Arthritis or Arthralgias (IMPACT 2.1)
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
AHS Cancer Control Alberta
Collaborators
—
Condition
Arthritis
Intervention
Methotrexate
Why stopped
Challenges in meeting the enrollment target
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-01-06